Navigation Links
ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
Date:6/13/2008

ate. Levels of C-reactive protein (CRP), a marker of inflammation and hemoglobin levels, showed significant and rapid improvement as early as two weeks in ACTEMRA (8 mg/kg) patients in the AMBITION trial, compared with patients treated with methotrexate alone.

"We are extremely pleased with these results which help us work toward establishing ACTEMRA as a new first-line biologic treatment, which blocks a different inflammatory target than current therapies. We are encouraged that we will soon be able to offer this new treatment option and meaningful benefit to those who need it the most -- the RA patients," said Lars Birgerson, M.D., Ph.D., Vice President, Global Head Medical Affairs, Roche.

About ACTEMRA (tocilizumab)

ACTEMRA is the first humanized interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody. Studies suggest that reducing the activity of IL-6, one of several key cytokines involved in the inflammatory process, may reduce inflammation of the joints and relieve certain systemic effects of RA. The extensive clinical development program conducted by Roche includes five clinical studies and has enrolled more than 4,000 patients in 41 countries, including the United States. Five Phase III studies are completed and have reported meeting their primary endpoints. The LITHE trial evaluating ACTEMRA in RA is an ongoing two-year study and is expected to report complete data evaluating the effects of ACTEMRA on the inhibition of structural joint damage in 2009. ACTEMRA is awaiting approval in the United States and Europe.

ACTEMRA is part of a co-development agreement with Chugai, a Japanese company. In June 2005, ACTEMRA was launched by Chugai in Japan as a therapy for Castleman's disease; in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan.

The serious adverse events reported in ACTEMRA clinical trials were se
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
2. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
3. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
4. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
5. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
6. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
7. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
10. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
11. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... , April 20, 2015 Actavis plc ... Charles M. Mayr , Chief Communications Officer, will ... health reasons.  In conjunction with Mayr,s retirement, ... the role of Chief Communications Officer, effective immediately. ... as Senior Vice President, Chief Communications Officer, Public ...
(Date:4/20/2015)... , April 20, 2015 Merrimack ... final clinical results for the Phase 1 study ... HER2-positive metastatic breast cancer.  The results were presented ... trials plenary oral session at the 2015 American ... Philadelphia, PA. Data described ...
(Date:4/20/2015)... -- This report analyzes the worldwide markets for Medical ... provides separate comprehensive analytics for the US, ... Rest of World. Annual estimates and forecasts are provided ... historic analysis is provided for these markets. Market data ... Company profiles are primarily based on public domain information ...
Breaking Medicine Technology:Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 2Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 3Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 4Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 5World Medical Equipment Rental and Leasing Industry 2World Medical Equipment Rental and Leasing Industry 3World Medical Equipment Rental and Leasing Industry 4World Medical Equipment Rental and Leasing Industry 5World Medical Equipment Rental and Leasing Industry 6World Medical Equipment Rental and Leasing Industry 7
... Oct. 6 MedInformatix , a leading provider ... PhoneTree , a developer and manufacturer of automated telecommunication ... at integrating MedInformatix, Electronic Medical Records (EMR) ... PhoneTree Patient Messaging ™.  The combined solutions, now ...
... NASHVILLE, Tenn. and GLEN ROCK, N.J., Oct. 6 ... rising costs of asthma and chronic obstructive pulmonary disease ... their formularies. According to the report entitled Formulary ... surveyed pharmacy directors expect asthma and COPD drug prices ...
Cached Medicine Technology:MedInformatix, PhoneTree Integrate Health Practice Products Via New Partnership 2MedInformatix, PhoneTree Integrate Health Practice Products Via New Partnership 3Due to Rising Costs of Asthma and Chronic Obstructive Pulmonary Disease Drugs, Managed Care Organization Pharmacy Directors Will be Forced to Tighten Their Formularies 2
(Date:4/21/2015)... NC (PRWEB) April 21, 2015 A ... survival rates among patients with peritoneal cancers like mesothelioma ... Surviving Mesothelioma has just posted the results of the ... . , Doctors at North Hampshire Hospital in ... with peritoneal malignancies such as mesothelioma between ...
(Date:4/21/2015)... April 21, 2015 Atlantic Information ... launch of Medicare-Medicaid Dual Eligibles Database, a brand-new, ... care provided to the more than 9 million ... for more than $300 billion in annual health ... the same team that also creates the industry-leading ...
(Date:4/21/2015)... Now, busy Diet Doc clients can bolster their metabolism ... breakfast omelets. Like Diet Doc’s other pre-packaged diet meals, ... are delivered directly to their door. Patients can choose from ... only appeal to the taste buds, but ensure that dieters ... low carbohydrate meals. , One of the only medical ...
(Date:4/21/2015)... TX (PRWEB) April 21, 2015 ... is actively involved in various components of breast ... fields. , "Breast reconstruction research continues ... mastectomy. Despite recent advances, many unanswered questions ... provide patients with optimal results," says Dr. Oscar ...
(Date:4/21/2015)... April 21, 2015 The Science Museum of ... special addition to its Lunch Break Science program. On Wednesday, ... Quarks! – taking guests from the subatomic world of quantum ... The Museum invites members of the community to grab lunch ... Lab physicist. Guests will delve into the nucleus and dissect ...
Breaking Medicine News(10 mins):Health News:New Findings Highlight Value of Experience in Peritoneal Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 2Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 3Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:Quarks and Forks at the Science Museum of Virginia 2
... likely to bear an underweight child, but some women ... genetic susceptibility.// The finding could help medicine better determine ... said they were not recommending at this point that ... ,"Our data demonstrate that a subgroup of ...
... the UK’s biggest killer, accounting for one in four ... key issue is that the diversity of lung disease ... have specialists who deal only in one disorder, chest ... obstructive pulmonary disorder(COPD), asthma, pneumonia, cystic fibrosis and sleep ...
... found that butterbur extract is an effective antihistamine without ... contains an active biochemical agent,// otherwise it would not ... might react with other medications. ,It was ... patients either butterbur extract tablets or the usually used ...
... Millions of Americans have been drinking tap water contaminated ... to disinfect drinking water.// When it is added to ... farms or lawns, however, it can form compounds such ... study released by the Environmental Working Group and Public ...
... save 40,000 more lives each year worldwide if more people ... took it, doctors said.// An analysis of nearly 300 ... to prevent blood clots confirmed that aspirin reduces heart attacks ... the people who could benefit from aspirin and anti-platelet therapy ...
... has launched Hyalosyn (sodium hyaluronate), an intra-articular injection that ... suffering from severe osteoarthritis. Osteoarthritis is a widely prevalent ... the age of 45 are estimated to show signs ... of disability in people above the age of 65. ...
Cached Medicine News:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: